We just returned from a trip to India to attend the SCRAC (Society of Cancer Research and Communication) meeting in the coastal town of Juhu, Mumbai, India. We had the opportunity to meet radiation oncologists and cancer specialists from the region, and to present our pitch for hyperthermia. We have received positive indications that there will be several Pyrexar Medical Hyperthermia suites installed in India in 2019.
India is projected to be the world's most populous country by 2024. Surpassing the population of China, it is expected to be home to more than 1.7 billion people by 2050. With this continuing growth, the demand for health services also grows. The opportunities in the country are vast and it appears hyperthermia has a chance to gain a foothold as a valuable adjunct cancer treatment.
SCRAC 2019 Program
Introduction to MRI Imaging - Dr. Mitusha Verma; Nanavati Hospital
Texture analysis - a novel technique in Radio-genomics - Dr. Balaji Ganeshan; Chief Executive Officer TexRAD Ltd UK
Introduction to MRI with Hyperthermia - Mr. Mark Falkowski, CEO; Pyrexar Medical
MRI to study heat induced changes for diagnostics and MRTI - Dr. Nagraj Huilgol; Nanavati Hospital
Group discussion to explore the possibilities to harness heat for diagnostics.